President Trump proposes a 200% tariff on drug imports to boost U.S. pharmaceutical production.

President Trump suggested imposing a 200% tariff on pharmaceutical imports during a Cabinet meeting, aiming to encourage drug manufacturers to produce in the US. The tariff would apply after a one-year adjustment period. The move could raise drug prices and lead to shortages, as pharmaceutical companies argue shifting production would require significant resources and time. Trump's proposal comes after a national security investigation into foreign medicine production.